Literature DB >> 6428642

Antidepressants and heart disease.

M L Orme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6428642      PMCID： PMC1442048          DOI： 10.1136/bmj.289.6436.1

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  21 in total

1.  Cardiac arrhythmia and imipramine therapy.

Authors:  K B Ramanathan; C Davidson
Journal:  Br Med J       Date:  1975-03-22

2.  Medicines evaluation and monitoring group. A follow-up study of cardiac patients receiving amitriptyline.

Authors:  D C Moir; I Dingwall-Fordyce; R D Weir
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

Review 3.  Mechanisms of lithium action.

Authors:  I Singer; D Rotenberg
Journal:  N Engl J Med       Date:  1973-08-02       Impact factor: 91.245

4.  Cardiotoxicity of amitriptyline.

Authors:  D C Moir; W B Cornwell; I Dingwall-Fordyce; J Crooks; K O'Malley; M J Turnbull; R D Weir
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

5.  Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system.

Authors:  D C Coull; J Crooks; I Dingwall-Fordyce; A M Scott; R D Wier
Journal:  Lancet       Date:  1970-09-19       Impact factor: 79.321

6.  Cardiovascular complications of imipramine intoxication.

Authors:  M H Sacks; R J Bonforte; R P Laser; I Dimich
Journal:  JAMA       Date:  1968-08-19       Impact factor: 56.272

7.  Imipramine-induced heart block. A longitudinal case study.

Authors:  S J Kantor; J T Bigger; A H Glassman; D L Macken; J M Perel
Journal:  JAMA       Date:  1975-03-31       Impact factor: 56.272

8.  Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.

Authors:  J R Mitchell; J H Cavanaugh; L Arias; J A Oates
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

9.  Effect of lithium on cardiovascular performance: report on extended ambulatory monitoring and exercise testing before and during lithium therapy.

Authors:  A G Tilkian; J S Schroeder; J Kao; H Hultgren
Journal:  Am J Cardiol       Date:  1976-11-23       Impact factor: 2.778

10.  Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs.

Authors:  J Vohra; G D Burrows; G Sloman
Journal:  Aust N Z J Med       Date:  1975-02
View more
  9 in total

1.  Cryptosporidium spa "new" human pathogen.

Authors:  D Casemore
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

2.  Heart disease in Asians in Britain.

Authors:  K M Fox; L M Shapiro
Journal:  BMJ       Date:  1988-07-30

3.  Pulmonary gas exchange during facemask ventilation immediately after birth.

Authors:  C Palme-Kilander; R Tunell
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

4.  Does routine ultrasound scanning improve outcome in pregnancy? Meta-analysis of various outcome measures.

Authors:  H C Bucher; J G Schmidt
Journal:  BMJ       Date:  1993-07-03

5.  Ethnicity as a variable in epidemiological research.

Authors:  P A Senior; R Bhopal
Journal:  BMJ       Date:  1994-07-30

6.  Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales.

Authors:  R Balarajan
Journal:  BMJ       Date:  1991-03-09

7.  The effect of the tricyclic antidepressant drug, nortriptyline on left ventricular ejection fraction and left ventricular volumes.

Authors:  O J Hartling; J Marving; P Knudsen; A Dahl; P F Høilund-Carlsen; L Hartling
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Comparative effects of fluoxetine and amitriptyline on cardiac function.

Authors:  J W Upward; J G Edwards; A Goldie; D G Waller
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 9.  Cryptosporidium species a "new" human pathogen.

Authors:  D P Casemore; R L Sands; A Curry
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.